AMENDMENT NO. 1 EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 8th, 2019 • Polarityte, Inc. • Biological products, (no disgnostic substances)
This is Amendment No. 1 (the “Amendment”) to the Executive Employment Agreement (“Agreement”) dated April 8, 2019, by and between PolarityTE, Inc., a Delaware corporation (“Parent”) and Richard Hague, an individual (“Executive”). Capitalized terms not defined herein, but defined in the Employment Agreement, shall have the meaning stated in the Employment Agreement.
AMENDMENT NO. 1 EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 8th, 2019 • Polarityte, Inc. • Biological products, (no disgnostic substances)
This is Amendment No. 1 (the “Amendment”) to the Executive Employment Agreement (“Agreement”) dated May 12, 2018, by and between PolarityTE, Inc., a Delaware corporation (“Parent”) and Paul Mann, an individual (“Executive”). Capitalized terms not defined herein, but defined in the Employment Agreement, shall have the meaning stated in the Employment Agreement.
AMENDMENT NO. 1 EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 8th, 2019 • Polarityte, Inc. • Biological products, (no disgnostic substances)
This is Amendment No. 1 (the “Amendment”) to the Executive Employment Agreement (“Agreement”) dated March 1, 2019, by and between PolarityTE, Inc., a Delaware corporation (“Parent”) and David Seaburg, an individual (“Executive”). Capitalized terms not defined herein, but defined in the Employment Agreement, shall have the meaning stated in the Employment Agreement.
